secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001628280-24-034954
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth Q2 revenue $806M (+1.6% YoY); net income $19.4M; narrows guidance
-----------------------------------------------------------------------------

- Net revenue $806.0M vs $793.3M YoY; net income $19.4M (+39%); adjusted EBITDA $165.3M (-3.3%).
- Year-to-date operating cash flow $247.0M (+$20.4M YoY); free cash flow $77.9M (+$23.1M).
- Signed definitive agreement to divest certain non-core assets; closing expected Q3 2024.
- FY2024 guidance: net revenue $3.255-3.315B, adj. EBITDA $660-700M, free cash flow $160-180M.
- CEO Suzanne Foster noted results in line with expectations; optimistic about unified team effort.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828024034954/0001628280-24-034954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828024034954/ahco-20240806.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-034954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer